Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.
The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical co...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4411125?pdf=render |
| _version_ | 1828341573297897472 |
|---|---|
| author | Andrie Koutsoulidou Tassos C Kyriakides George K Papadimas Yiolanda Christou Evangelia Kararizou Eleni Zamba Papanicolaou Leonidas A Phylactou |
| author_facet | Andrie Koutsoulidou Tassos C Kyriakides George K Papadimas Yiolanda Christou Evangelia Kararizou Eleni Zamba Papanicolaou Leonidas A Phylactou |
| author_sort | Andrie Koutsoulidou |
| collection | DOAJ |
| description | The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical conditions. Myotonic Dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy primarily characterized by muscle myotonia, weakness and atrophy. Previous studies have shown an association between miRNAs and DM1 in muscle tissue and, recently, in plasma. The aim of this study was to detect and assess muscle-specific miRNAs as potential biomarkers of DM1 muscle wasting, an important parameter in the disease's natural history. Disease stable or progressive DM1 patients with muscle weakness and wasting were recruited and enrolled in the study. RNA isolated from participants' serum was used to assess miRNA levels. Results suggest that the levels of muscle-specific miRNAs are correlated with the progression of muscle wasting and weakness observed in the DM1 patients. Specifically, miR-1, miR-133a, miR133b and miR-206 serum levels were found elevated in DM1 patients with progressive muscle wasting compared to disease stable DM1 patients. Based on these results, we propose that muscle-specific miRNAs might be useful molecular biomarkers for monitoring the progress of muscle atrophy in DM1 patients. |
| first_indexed | 2024-04-13T23:15:41Z |
| format | Article |
| id | doaj.art-ed3e66be361d44caa22683bd199b7b3f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T23:15:41Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-ed3e66be361d44caa22683bd199b7b3f2022-12-22T02:25:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012534110.1371/journal.pone.0125341Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.Andrie KoutsoulidouTassos C KyriakidesGeorge K PapadimasYiolanda ChristouEvangelia KararizouEleni Zamba PapanicolaouLeonidas A PhylactouThe discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical conditions. Myotonic Dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy primarily characterized by muscle myotonia, weakness and atrophy. Previous studies have shown an association between miRNAs and DM1 in muscle tissue and, recently, in plasma. The aim of this study was to detect and assess muscle-specific miRNAs as potential biomarkers of DM1 muscle wasting, an important parameter in the disease's natural history. Disease stable or progressive DM1 patients with muscle weakness and wasting were recruited and enrolled in the study. RNA isolated from participants' serum was used to assess miRNA levels. Results suggest that the levels of muscle-specific miRNAs are correlated with the progression of muscle wasting and weakness observed in the DM1 patients. Specifically, miR-1, miR-133a, miR133b and miR-206 serum levels were found elevated in DM1 patients with progressive muscle wasting compared to disease stable DM1 patients. Based on these results, we propose that muscle-specific miRNAs might be useful molecular biomarkers for monitoring the progress of muscle atrophy in DM1 patients.http://europepmc.org/articles/PMC4411125?pdf=render |
| spellingShingle | Andrie Koutsoulidou Tassos C Kyriakides George K Papadimas Yiolanda Christou Evangelia Kararizou Eleni Zamba Papanicolaou Leonidas A Phylactou Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. PLoS ONE |
| title | Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. |
| title_full | Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. |
| title_fullStr | Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. |
| title_full_unstemmed | Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. |
| title_short | Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. |
| title_sort | elevated muscle specific mirnas in serum of myotonic dystrophy patients relate to muscle disease progress |
| url | http://europepmc.org/articles/PMC4411125?pdf=render |
| work_keys_str_mv | AT andriekoutsoulidou elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT tassosckyriakides elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT georgekpapadimas elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT yiolandachristou elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT evangeliakararizou elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT elenizambapapanicolaou elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress AT leonidasaphylactou elevatedmusclespecificmirnasinserumofmyotonicdystrophypatientsrelatetomusclediseaseprogress |